Daily

South Dakota startup raises $1M for its “eyegraine” system that treats vision-related migraines

There’s a link between migraines and vision problems – if there’s a misalignment in the way two eyes see an object, brain nerves are overstimulated and end up causing those thumping headaches. South Dakota startup EyeBrain Medical has raised $1 million, according to a regulatory filing, for its technology that’s meant to reduce chronic headaches without surgery […]

There’s a link between migraines and vision problems – if there’s a misalignment in the way two eyes see an object, brain nerves are overstimulated and end up causing those thumping headaches.

South Dakota startup EyeBrain Medical has raised $1 million, according to a regulatory filing, for its technology that’s meant to reduce chronic headaches without surgery or medication – just a new pair of glasses. Its technology that merges neurological principles with advanced eye care. The company’s created a system to allow docs to “calculate and map the imbalance between the eyes and brain.”

It’s then created “NeuroLenses” – prescription glasses – that are designed to correct these imbalances. Prairie Business profiled the company in April:

Dr. Carol Miles, medical director of The Headache Center of Neurology Associates, said in a news release that people who think they suffer from chronic headaches may actually be suffering from a new-found class of headaches called eyeGraines.

“When the images for each eye are not properly aligned, the brain struggles to fuse them together. This struggle repeated over and over can lead to ‘eyeGraines,'” Miles said in the release.

In preliminary studies, 80 percent of patients experienced reduced or, in some cases, eliminated chronic headaches after using NeuroLens technology, according to the release.

“Working in conjunction with specialists in the eye care field, we have found a way to treat the disparity between visual and neurological systems,” Miles said. “We believe when these two systems are out of balance, it often manifests itself in chronic, severe headaches.”